Autres langues Tanvex BioPharma, Inc.

Actions

6541

KYG8676P1037

Cours en clôture Taiwan S.E. Autres places de cotation 00:00:00 14/05/2024			Varia. 5j.	Varia. 1 janv.
42,2 ^TWD	-3,10%		-1,97%	-35,18%

14/03	Tanvex BioPharma, Inc. annonce ses résultats pour l'exercice clos le 31 décembre 2023	CI
06/02	Tanvex BioPharma, Inc. annonce la nomination de James Williamson en tant qu'agent comptable	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Tanvex BioPharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	14/03
Tanvex BioPharma, Inc. Announces the Appointment of James Williamson as Accounting Officer	06/02
Tanvex BioPharma, Inc. Announces the Appointment of Chen, Lin-Cheng as CEO	06/02
Tanvex Biologics Corporation announced that it expects to receive $5 million in funding from Tanvex BioPharma, Inc.	06/02
Tanvex BioPharma USA, Inc. announced that it expects to receive $50 million in funding from Tanvex BioPharma, Inc.	06/02
Tanvex BioPharma, Inc. Announces the Resignation of Ken Huang as Accounting Officer	05/01
Tanvex BioPharma, Inc. Announces Change of Chairman	29/12
Tanvex BioPharma, Inc. Announces Resignation of Yun Yen Chairperson and Director, Effective December 29, 2023	21/12
Tanvex BioPharma, Inc. Announces Change of Corporate Governance Officer	21/12
Tanvex BioPharma, Inc. Announces Resignation of Yun Yen as CEO, Effective December 29, 2023	21/12
Tanvex BioPharma, Inc. Announces Resignation of Yun Yen as Chairman/President, Effective December 29, 2023	21/12
Tanvex BioPharma, Inc. Announces the Resignation of Stacey Tsai as Acting Spokesperson and Corporate Governance Officer	30/11
Tanvex BioPharma, Inc. Appoints Wen Chung Yeh as Chief Financial Officer	13/11
Tanvex BioPharma, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	13/11
Tanvex BioPharma, Inc. Announces Management Changes	01/11
Tanvex BioPharma, Inc.(TWSE:6541) added to S&P Global BMI Index	18/09/23
Tanvex BioPharma, Inc.(TWSE:6541) added to Taiwan TAIEX Index	07/09/23
Tanvex BioPharma, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	09/08/23
Tanvex BioPharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	15/05/23
Tanvex BioPharma, Inc.(TWSE:6541) dropped from Taiwan TAIEX Index	12/04/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Tanvex BioPharma, Inc.

Actions

6541

KYG8676P1037

Autres langues

Filtres